Virax Biolabs
London, United Kingdom · Biotechnology, Health Care, Manufacturing
Virax Biolabs Group Limited is an innovative biotech company founded in 2013 that focuses on detecting immune responses and diagnosing viral diseases, distributing a range of in-vitro diagnostic test kits while developing proprietary T-Cell Test technology aimed at providing an immunology profiling platform to assess individual immune risk against major global viral threats, including COVID-19, Mo
Key facts
- Headquarters
- London, United Kingdom
- Employees
- 19
- Industries
- Biotechnology, Health Care, Manufacturing
- Status
- Public (VRAX)
- Website
- www.viraxbiolabs.com
- Company page
Recent activity at Virax Biolabs
- : Virax Biolabs Enters Multi-Country Commercial Supply Agreement with Fosun Diagnostics for ImmuneSelect Products.
- : Virax Biolabs Group Limited has announced a $5 million Private Placement to support working capital and corporate purposes, with H.C. Wainwright & Co. as the placement agent.
- : Virax Biolabs and Cosmos Health Inc. Extend Exclusive Distribution Agreement for Mpox Virus Real-Time PCR Detection Kits
- : Virax Biolabs Group Appoints Dr. Nigel McCracken as Chief Operating Officer to Oversee Growth Momentum
- : Virax Biolabs Group Ltd
Virax Biolabs funding history
| Date | Round | Amount |
|---|---|---|
| Dec 2025 | Post-IPO Equity | $5.0M |
| Mar 2023 | Venture | $4.0M |
Leadership
- James Foster, Founder & Chief Executive Officer
- Nigel McCracken, Chief Operating Officer
- Cameron Shaw, Chief Operating Officer
Verified email and direct lines for Virax Biolabs’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Virax Biolabs in the news
- Virax Biolabs Group Limited (VRAX) Company Information - Simply Wall St (Nov 03, 2026)
- Virax Biolabs Group Limited Announces 1-for-25 Share Consolidation - Yahoo Finance (Jun 24, 2026)
- Virax Biolabs Appoints Three Distributors for ImmuneSelect Research Products in Mainland China - PR Newswire (Oct 29, 2026)
- Virax Biolabs signs supply pact for six Southeast Asian markets - Stock Titan (Jul 09, 2026)
- Virax Biolabs Group Limited (VRAX) company profile and facts - Yahoo Finance UK (Jun 30, 2024)
- Virax Biolabs Group Limited (VRAX) stock price, news, quote and history - Yahoo Finance Australia (Aug 03, 2022)
Companies similar to Virax Biolabs
- SymPhysis Medical · Biotechnology, Health Care, Manufacturing, Therapeutics
- Prokarium · Biotechnology, Health Care, Manufacturing, Therapeutics
- Cerenome, Inc. · Biotechnology, Health Care, Manufacturing, Therapeutics
- Merakris Therapeutics · Biotechnology, Health Care, Manufacturing, Therapeutics
- Smartlens · Biotechnology, Health Care, Manufacturing, Therapeutics
About Virax Biolabs: questions and answers
What does Virax Biolabs do?
Virax Biolabs Group Limited is an innovative biotech company founded in 2013 that focuses on detecting immune responses and diagnosing viral diseases, distributing a range of in-vitro diagnostic test kits while developing proprietary T-Cell Test technology aimed at providing an immunology profiling platform to assess individual immune risk against major global viral threats, including COVID-19, Mo
Where is Virax Biolabs headquartered?
Virax Biolabs is headquartered in London, United Kingdom.
How many employees does Virax Biolabs have?
Virax Biolabs has about 19 employees.
Has Virax Biolabs raised funding?
Yes. Fundz has recorded 2 funding events for Virax Biolabs. The most recent, Post-IPO Equity of $5.0M, was in Dec 2025.
Who leads Virax Biolabs?
James Foster is a Founder & Chief Executive Officer at Virax Biolabs.
What is the latest news on Virax Biolabs?
On Jul 09, 2026, Virax Biolabs Enters Multi-Country Commercial Supply Agreement with Fosun Diagnostics for ImmuneSelect Products.
Is Virax Biolabs a public company?
Yes. Virax Biolabs is publicly traded under the ticker VRAX.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy